If you realize you added the wrong amount of liquid, do not guess the new dosage
However, the regulatory framework for drug development relies heavily on animal toxicology precisely because it does provide meaningful safety signals
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
Heres what we work with: GLP-1 weight loss peptides Semaglutide and tirzepatide for appetite regulation, metabolic improvement, and sustainable fat loss
Humira USD 9.0B (declining)
Whether it's for routine wellness or a specific health concern, we're here to assist you on your journey to a healthier, happier you.
